How Australia can fix the market for plasma and save millions

September 4, 2018 by Robert Slonim, The Conversation
Australians aren’t paid for their donations even though donors overseas are. Credit: Shutterstock

Australia's demand for plasma, a component of blood that transports nutrients, is rapidly outpacing domestic supply. This means enormous quantities of plasma must be imported from overseas, where donors are paid for donating.

Two factors can help explain the shortfall. First, the Australian Red Cross Blood Service has a monopoly to collect all products in Australia. Second, Australia's donors receive no financial .

These two factors limit the domestic supply of plasma, is unjust for Australian donors and makes domestic collections financially burdensome.

Australia needs a competitive market that pays plasma donors. This would address the injustice to Australian donors and potentially save taxpayers over A$200M annually.

Plasma is used for people suffering from burns, shock and other medical emergencies and its components are used to treat rare chronic conditions.

In contrast to whole blood which can only be stored for a maximum of six weeks, plasma donations are highly processed, and can be stored for a year or longer.

Donating plasma takes up to one and a half hours, including around 45 minutes "needle-in" time. During this time, blood cycles through equipment that separates plasma from other blood parts, which are returned to the .

For and against compensating donors

In one of the classic texts on social policy, Richard Titmuss claimed paying donors would reduce blood supply and safety.

Titmuss argued compensation would reduce donations by eroding the spirit of volunteerism to help others and would threaten safety because compensation would attract donors with greater likelihood of having transmissible diseases.

This concern seemed justified in the 1980s during the AIDS epidemic. And this encouraged Australia's policy of not compensating donors for blood products.

But much has changed since the 1970s. Careful screening and medical advancements have eliminated virtually all safety concerns.

And, contrary to notions that compensation diminishes donations, research overwhelmingly shows incentives substantially increase donations.

My colleagues and I reviewed many studies. We found that of the 19 different incentives offered, 18 increased donations significantly and none ever reduced donations or harmed safety.

In our study with the American Red Cross, donors were 30% more likely to donate if offered $10 gift cards than if only asked to volunteer.

To examine how compensation will affect Australian donations, I conducted a survey asking Australians "how likely" and "how often" they would donate in the next year.

Some respondents, randomly assigned, were asked these questions when not being offered any compensation. The others were asked the same questions when being offered A$50. A$50 is about the average amount that international donors are offered.

Consistent with the previous research, those offered compensation were 20 percentage points more likely to say they would donate than those not offered compensation (60% vs. 40%).

Further, respondents offered compensation indicated they would make over three more plasma donations per year than those not offered compensation.

The chart below shows those offered compensation will donate more than those not offered compensation regardless of whether the study participants had never donated (will donate 3.3 times if offered compensation vs. 0.5 times if not offered compensation); had donated, but not recently (4.2 vs. 0.8) or had donated recently (6.9 vs. 2.9).

Creating a fairer and less costly system

Not compensating Australia's approximately 150,000 plasma donors for their time is unfair given its enormous value to society, and especially considering we pay for plasma that comes from international donors who are paid for the equivalent donation.

The National Blood Authority's 2016-2017 annual report indicates Australian imports of immunoglobulin, a plasma component, provide 44% of domestic demand. This costs A$120 million while the remaining 56% comes from domestic supply costing A$413 million.

This implies the domestic supply of immunoglobulin costs over three times more per unit than what is imported, despite domestic donors not being compensated.

It also implies Australia could save over A$200M annually by importing all immunoglobulin.

Likely culprits for the higher domestic costs include the Red Cross Blood Service's monopoly powers and not compensating donors. Since not offering compensation limits donations, it likely increases other costs, including recruiting donors.

And the Blood Service's monopoly position reduces the normal competitive market motives to constantly search for the most cost effective collection methods.

Given lower international prices, one way to save money is to collect more plasma abroad and less domestically. A much more desirable solution would be to introduce a (regulated) competitive domestic market for plasma.

A competitive domestic market should successfully develop following the international market model, would provide new business opportunities and allow compensation to land in Australian rather than international donors' pockets.

Concerns should be no different for plasma coming from a domestic than international market, and the domestic market could be better as we can tailor regulations to our needs rather than rely on international market rules.

To save taxpayer money and treat Australian donors more fairly, a competitive for supply is necessary.

Explore further: Red Cross issues nationwide call for blood donations

Related Stories

Red Cross issues nationwide call for blood donations

July 10, 2018
(HealthDay)—Following a blood shortage triggered by the Fourth of July holiday week, the American Red Cross has called for donations of all blood types, but especially type O.

Blood banks need January donors

January 9, 2018
(HealthDay)—Want to make a difference right now? Consider donating some blood.

Demand for stool donors grows as benefits of fecal microbiota transplant are recognized

June 5, 2018
Appealing to a concern for others is the best way to recruit most people to donate their stool for medicine, while cash rewards may be an additional motivator for some potential donors, according to research scheduled for ...

Red Cross issues emergency call for blood donations

July 10, 2013
(HealthDay)—The American Red Cross is sending out an emergency request for blood donors after a recent dip in donations.

Prohibiting sperm donor anonymity could reduce the number of donors

November 30, 2016
A new study published in the Journal of Law and the Biosciences suggests that prohibiting anonymous sperm donation would result in a decline in the number of donors, and that those willing to donate would likely demand compensation ...

Blood donors needed after East Coast storm: Red Cross

January 27, 2016
(HealthDay)—Jonas, the massive snowstorm that hammered the East Coast, has led to a shortage of blood products and there is an emergency need for both blood and platelet donors, the American Red Cross said Tuesday.

Recommended for you

Funder involved in all aspects of most industry-funded clinical trials

October 3, 2018
In most industry funded trials reported in high impact medical journals, all aspects of the trial involved the industry funder, finds a study published by The BMJ today.

Educating the next generation of medical professionals with machine learning is essential

September 27, 2018
Artificial intelligence (AI) driven by machine learning (ML) algorithms is a branch in the field of computer science that is rapidly gaining popularity within the healthcare sector. However, graduate medical education and ...

Here's one reason why US healthcare costs so much

September 11, 2018
There is substantial waste in U.S. healthcare, but little consensus on how to identify or combat it.

New study examines predictors of patient-reported experiences at dialysis facilities

September 11, 2018
For patients with end-stage renal disease, dialysis treatments are vital and often are payed for by Medicare. In 2012, Medicare implemented a Quality Incentive Program scoring system, and in 2016, patient-reported experiences ...

Burnout in doctors has shocking impact on care, review finds

September 5, 2018
Burnout in doctors has devastating consequences on the quality of care they deliver, according to a large-scale systematic review and meta-analysis.

Who wins when a prescription copay exceeds the drug price? Not the patient

August 31, 2018
Prescription drug copayments often exceed the retail cost of a drug, a recent USC study reveals. This means that technically an overpayment occurs, and someone—not the patient—keeps the excess payment.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.